These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8386406)

  • 41. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients.
    Sagedal S; Nordal KP; Hartmann A; Sund S; Scott H; Degré M; Foss A; Leivestad T; Osnes K; Fauchald P; Rollag H
    Am J Transplant; 2002 Oct; 2(9):850-6. PubMed ID: 12392291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L; Steinhoff J; Hartwig-Weber I; Bein G
    Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The utility of urine cytology in the diagnosis of allograft rejection after combined pancreas-kidney transplantation.
    Radio SJ; Stratta RJ; Taylor RJ; Linder J
    Transplantation; 1993 Mar; 55(3):509-16. PubMed ID: 8384382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased early mortality in women undergoing cardiac transplantation.
    Wechsler ME; Giardina EG; Sciacca RR; Rose EA; Barr ML
    Circulation; 1995 Feb; 91(4):1029-35. PubMed ID: 7850938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
    Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
    Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
    Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An association between cytomegalovirus infection and chronic rejection after liver transplantation.
    Evans PC; Soin A; Wreghitt TG; Taylor CJ; Wight DG; Alexander GJ
    Transplantation; 2000 Jan; 69(1):30-5. PubMed ID: 10653376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival.
    Smedbråten YV; Sagedal S; Leivestad T; Mjøen G; Osnes K; Rollag H; Reisaeter AV; Foss A; Os I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):120-6. PubMed ID: 24351078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of ganciclovir prophylaxis on cytomegalovirus infection in recipients of cadaveric renal allografts.
    Ram Peddi V; Hariharan S; Schroeder TJ; First MR
    Nephron; 1997; 76(1):49-55. PubMed ID: 9171300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of rheumatoid factors in renal transplant recipients with cytomegalovirus infection and not with rejection.
    Baldwin WM; Westedt ML; van Gemert GW; Henny FC; Paul LC; Daha MR; van Es LA
    Transplantation; 1987 May; 43(5):658-62. PubMed ID: 3033854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.
    Hornef MW; Bein G; Fricke L; Steinhoff J; Wagner HJ; Hinderer W; Sonneborn HH; Kirchner H
    Transplantation; 1995 Sep; 60(5):474-80. PubMed ID: 7676497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of cytomegalovirus infection after pancreas transplantation.
    Parsaik AK; Bhalla T; Dong M; Rostambeigi N; Dierkhising RA; Dean P; Abraham R; Prieto M; Kremers WK; Razonable RR; Kudva YC
    Transplantation; 2011 Nov; 92(9):1044-50. PubMed ID: 21904269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Research of mHLA-G and the receptor expression with kidney rejection and CMV active infection following kidney transplantation].
    Bi LL; Gao Y; Sun YJ; Kong XR; He XY; Ma XH; Zhang WH; Xiao L; Shi BY
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):104-107. PubMed ID: 28088953
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients.
    Humar A; Uknis M; Carlone-Jambor C; Gruessner RW; Dunn DL; Matas A
    Transplantation; 1999 Jan; 67(1):94-7. PubMed ID: 9921803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1,25 Dihydroxyvitamin D circulating levels, calcitriol administration, and incidence of acute rejection, CMV infection, and polyoma virus infection in renal transplant recipients.
    Moscarelli L; Antognoli G; Buti E; Dervishi E; Fani F; Caroti L; Tsalouchos A; Romoli E; Ghiandai G; Minetti E
    Clin Transplant; 2016 Oct; 30(10):1347-1359. PubMed ID: 27532453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
    Abou-Ayache R; Büchler M; Lepogamp P; Westeel PF; Le Meur Y; Etienne I; Lobbedez T; Toupance O; Caillard S; Goujon JM; Bergougnoux L; Touchard G
    Nephrol Dial Transplant; 2008 Jun; 23(6):2024-32. PubMed ID: 18199693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
    Pollak R; Barber PL; Prusak BF; Mozes MF
    Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.